by AvisB | Sep 22, 2020 | News
Avis Bulbulyan, CEO of marijuana consultant group SIVA Enterprises, worked with a Black-owned business that received a social equity designation when applying for a license. He and Hatchett said they are still concerned that firms that are not at least 51-percent...
by AvisB | Sep 18, 2020 | News
Cannabis reform activists, industry representatives, and lawmakers were quick to react to the postponement of the vote on the MORE Act. Maritza Perez, director of the office of national affairs at the Drug Policy Alliance, said in a statement that the delay will...
by AvisB | Aug 11, 2020 | News
Since its peak in August 2018 in the run-up to Canada’s legalization of recreational weed, cannabis stocks tracker MJ ETF has dropped 70%. M&A fell 80% and capital raising slumped 70% to $2.71 billion through July 31, according to the Viridian cannabis deal...
by AvisB | Jul 31, 2020 | News
Those in the marijuana industry supported the inclusion of the Blumenauer amendment but noted that it doesn’t change the fact that marijuana is still illegal at the federal level. “Any inclusion that addresses protections for the cannabis industry is...
by AvisB | Jul 8, 2020 | News
Entry-level insurance premiums for cannabis industry directors and officers of public companies has more than doubled as lawsuits by investors claiming fraud and misinformation are on the rise, Reuters reports. The insurance can now run as much as $250,000 for...
by AvisB | Jul 8, 2020 | News
TORONTO — Canadian and U.S. cannabis companies are facing a spike in already high costs of insurance to protect top executives from personal liability, following a slew of lawsuits by disgruntled investors alleging fraud and misinformation, with more such action...
